BRENDA MILNER: Open Payments
NPI 1184372443 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 42 payments from 14 companies in 2025. Trend: 2023 $1,106 · 2024 $1,445 · 2025 $1,029
Food & beverage: $1,010Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $197 |
| SCPHARMACEUTICALS INC. | 3 | $152 |
| Amgen Inc. | 2 | $132 |
| Merck Sharp & Dohme LLC | 6 | $106 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Philips North America LLC | 2 | $42 |
| Shockwave Medical, Inc | 1 | $37 |
Products named: FUROSCIX, REPATHA, FARXIGA, VERQUVO, LifeVest, WAINUA, LEQVIO, JARDIANCE.
Industry payments across AL — which companies pay providers there.
